In The Press:
IAM Reports on NATURE published paper "Differing Diagnoses for European and US Patents by Alan Miller, Ph.D and Brian Amos Ph.D
May 17, 2017Adding to that growing discrepancy between the US and other major patent jurisdictions, a more recent paper from two private practice lawyers found that the Supreme Court’s decision in Mayo v Prometheus is having a significant effect on applications for medical diagnostic patents. The authors, Brian Amos and Alan Miller. from Amster, Rothstein & Ebenstein, looked at 31 Patent Cooperation Treaty (PCT) diagnostic applications and compared the fate of those filings in the US and Europe. While 30 of the 31 were allowed or pending (with no 101 rejection equivalent) in Europe, in the US just two had made it through, with the remaining 29 either abandoned or pending having received a 101 Mayo rejection. The Intellectual Property Watch website picked up on the paper and you can see its story here.
The Amos and Miller study is based on a small sample, but the degree to which applications have been rejected should still act as a wake-up call in the US and a sharp reminder that eligibility concerns are not all about business methods and software.
View all In the Press
Upcoming Events
-
April 23, 2024 – April 24, 2024
Research & Innovation in Healthcare 2024 ConferenceLocation: Baylor Scott & White Charles A. Sammons Cancer Center, Dallas, Texas (Registration Required)Speaker(s): Charles R. Macedo,
-
April 30, 2024 – May 2, 2024
AUTM Canadian Region Meeting 2024Location: Doubletree by Hilton Toronto Downtown, Toronto, Ontario (Registration Required)Speaker(s): Charles R. Macedo,
RSS FEED
Never miss another publication. Our RSS feed (what is RSS?) will inform you when new articles have been posted.
Subscribe now!